1. |
Fatourechi V. Thyroid dermopathy and acropachy. Best Pract Res Clin Endocrinol Metab, 2012, 26(4): 553-565.
|
2. |
Anderson CK, Miller OF. Triad of exophthalmos, pretibial myxedema, and acropachy in a patient with Graves’ disease. J Am Acad Dermatol, 2003, 48(6): 970-972.
|
3. |
Chang TC, Wu SL, Hsiao YL, et al. TSH and TSH receptor antibody-binding sites in fibroblasts of pretibial myxedema are related to the extracellular domain of entire TSH receptor. Clin Immunol Immunopathol, 1994, 71(1):113-120.
|
4. |
Stadlmayr W, Spitzweg C, Bichlmair AM, et al. TSH receptor transcripts and TSH receptor-like immunoreactivity in orbital and pretibial fibroblasts of patients with Graves’ ophthalmopathy and pretibial myxedema. Thyroid, 1997, 7(1): 3-12.
|
5. |
Daumerie C, Ludgate M, Costagliola S, et al. Evidence for thyrotropin receptor immunoreactivity in pretibial connective tissue from patients with thyroid-associated dermopathy. Eur J Endocrinol, 2002, 146(1): 35-38.
|
6. |
Rapoport B, Alsabeh R, Aftergood D, et al. Elephantiasic pretibial myxedema: insight into and a hypothesis regarding the pathogenesis of the extrathyroidal manifestations of Graves’ disease. Thyroid, 2000, 10(8): 685-692.
|
7. |
Missner SC, Ramsay EW, Houck HE, et al. Graves’ disease presenting as localized myxedema in a thigh donor graft site. J Am Acad Dermatol, 1998, 39(5 Pt 2): 846-849.
|
8. |
但昭葵, 薛君力. 甲亢合并胫前粘液性水肿 1 例. 大连医科大学学报, 2017(4): 409-410.
|
9. |
Cho S, Choi JH, Sung KJ, et al. Graves’disease presenting as elephantiasic pretibial myxedema and nodules of the hands. Int J Dermatol, 2001, 40(4): 276-277.
|
10. |
Deng A, Song D. Multipoint subcutaneous injection of long-acting glucocorticid as a cure for pretibial myxedema. Thyroid, 2011, 21(1): 83-85.
|
11. |
谭芳, 余叶蓉. 胫前粘液性水肿的临床诊治. 实用医院临床杂志, 2014(1): 26-28.
|